Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 946-952

  Park, Eun Jung ^a   Park, Hyen Joo ^b   Chung, Hwa Jin ^b   Shin, Yoonho ^b   Min, Hye Young ^a   Hong, Ji Young ^a   Kang, You Jin ^a   Ahn, Yong Hyun ^c   Pyee, Jae Ho ^c   Kook Lee, Sang ^b  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Dankook University   (South Korea)

Author keywords

Antimetastasis; Cyclooxygenase 2 (COX 2); Matrix metalloproteinase (MMP); Pinosylvin; Pulmonary metastasis model

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PINOSYLVIN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; FIBROSARCOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMOPREVENTION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; HUMANS; LUNG NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PHOSPHORYLATION; STILBENES;

MUS;

EID: 84864007836     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.021     Document Type: Article

References (44)

1. Yoon S.O., Park S.J., Yun C.H., Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003, 36:128-137.
2. Vlodavsky I., Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001, 108:341-347.
3. Engers R., Gabbert H.E. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000, 126:682-692.
4. Westermarck J., Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999, 13:781-792.
5. Park B.C., Thapa D., Lee Y.S., Kwak M.K., Lee E.S., Choi H.G., et al. 1-Furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. Eur J Pharmacol 2007, 567:193-197.
6. Yoon S.O., Shin S., Lee H.J., Chun H.K., Chung A.S. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 2006, 5:2666-2675.
7. Van Ta Q., Kim M.M., Kim S.K. Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080). Mar Biotechnol (NY) 2006, 8:593-599.
8. Park J.M., Kim A., Oh J.H., Chung A.S. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. Carcinogenesis 2007, 28:837-847.
9. Yoshinaka R., Shibata M.A., Morimoto J., Tanigawa N., Otsuki Y. COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer. Anticancer Res 2006, 26:4245-4254.
10. Ishizaki T., Katsumata K., Tsuchida A., Wada T., Mori Y., Hisada M., et al. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int J Mol Med 2006, 17:357-362.
11. Yao M., Lam E.C., Kelly C.R., Zhou W., Wolfe M.M. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer 2004, 90:712-719.
12. Soares D.G., Andreazza A.C., Salvador M. Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem 2003, 51:1077-1080.
13. Wolter F., Clausnitzer A., Akoglu B., Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 2002, 132:298-302.
14. Lee S.H., Shin N.H., Kang S.H., Park J.S., Chung S.R., Min K.R., et al. Alpha-viniferin: a prostaglandin H2 synthase inhibitor from root of Carex humilis. Planta Med 1998, 64:204-207.
15. Huang K.S., Zhou S., Lin M., Wang Y.H. An isorhapontigenin tetramer and a novel stilbene dimer from Gnetum hainanense. Planta Med 2002, 68:916-920.
16. Jorgensen E. The formation of pinosylvin and its monomethyl ether in the sapwood of Pinus resinosa ait. Can J Botany 1961, 39:1765-1772.
17. Fang J.G., Lu M., Chen Z.H., Zhu H.H., Li Y., Yang L., et al. Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry 2002, 8:4191-4198.
18. Ohguchi K., Tanaka T., Kido T., Baba K., Iinuma M., Matsumoto K., et al. Effects of hydroxystilbene derivatives on tyrosinase activity. Biochem Biophys Res Commun 2003, 307:861-863.
19. Pacher T., Seger C., Engelmeier D., Vajrodaya S., Hofer O., Greger H. Antifungal stilbenoids from Stemona collinsae. J Nat Prod 2002, 65:820-827.
20. Park E.J., Min H.Y., Ahn Y.H., Bae C.M., Pyee J.H., Lee S.K. Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E2 production in lipopolysaccharide-induced mouse macrophage cells. Bioorg Med Chem Lett 2004, 14:5895-5898.
21. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method 1996, 25:402-408.
23. Brattain M.G., Strobel-Stevens J., Fine D., Webb M., Sarrif A.M. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res 1980, 40:2142-2146.
24. Fidler I.J. General considerations for studies of experimental cancer metastasis. Methods. Cancer Res 1978, 151:399-439.
25. Hwang H.J., Park H.J., Chung H.J., Min H.Y., Park E.J., Hong J.Y., et al. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. J Nutr Biochem 2006, 17:356-362.
26. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Internat 2004, 11:36-42.
27. Amir M., Agarwal H.K. Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 2005, 60:563-570.
28. Zucker S., Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-117.
29. Vasala K., Pääkkö P., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology 2003, 62:952-957.
30. Menon L.G., Kuttan R., Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 1995, 95:221-225.
31. Gagliano N., Moscheni C., Torri C., Magnani I., Bertelli A.A., Gioia M. Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and secreted protein acidic and rich in cysteine (SPARC) on human cultured glioblastoma cells. Biomed Pharmacother 2005, 59:359-364.
32. Yu H., Pan C., Zhao S., Wang Z., Zhang H., Wu W. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 2008, 62:366-372.
33. Sun C.Y., Hu Y., Guo T., Wang H.F., Zhang X.P., He W.J., et al. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity. Acta Pharmacol Sin 2006, 27:1447-1452.
34. Lee J., Jung E., Lim J., Lee J., Hur S., Kim S.S., et al. Involvement of nuclear factor-kappaB in the inhibition of pro-inflammatory mediators by pinosylvin. Planta Med 2006, 72:801-806.
35. Chen W.S., Wei S.J., Liu J.M., Hsiao M., Kou-Lin J., Yang W.K. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 2001, 91:894-899.
36. Naruse T., Nishida Y., Hosono K., Ishiguro N. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 2006, 27:584-592.
37. Simon C., Hicks M.J., Nemechek A.J., Mehta R., O'Malley B.W., Goepfert H., et al. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer 1999, 80:1412-1419.
38. Brown R., Marshall C.J., Pennie S.G., Hall A. Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. EMBO J 1984, 3:1321-1326.
39. Paterson H., Reeves B., Brown R., Hall A., Furth M., Bos J., et al. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 1987, 51:803-812.
40. Plattner R., Gupta S., Khosravi-Far R., Sato K.Y., Perucho M., Der C.J., et al. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Oncogene 1999, 18:1807-1817.
41. Kim D., Kim S., Koh H., Yoon S.O., Chung A.S., Cho K.S., et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 2001, 15:1953-1962.
42. Fan S.Q., Wei Q.Y., Li M.R., Zhang L.Q., Liang Q.C. Expression and clinical significance of MMP-2, MMP-9, TIMP-1, and TIMP-2 in breast carcinoma. Ai Zheng 2003, 22:968-973.
43. Chirco R., Liu X.W., Jung K.K., Kim H.R. Novel functions of TIMPs in cell signaling. Cancer Metasta Rev 2006, 25:99-113.
44. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 23:659-661.